Antonio Steardo
Pharmaceutical and Professional Consultant, Italy
Title: Products containing free cannabis, appropriate pharmacovigilance asset to a better quality of everyday life through better safety and efficacy
Biography
Biography: Antonio Steardo
Abstract
Following decades of research, the retrieval of components in Cannabis has made feasible the study of several psychotropic and non-psychotropic compounds that this herb and its variants contain. Useful new non-medical products have appeared on the market and this presentation aims to assess the pharmacological impact these on a wide population of consumers.
Nowadays, a broad variety of cosmetics, food, supplements, and many other products attract wide-ranging consumption on the market.
This presentation aims to discuss and introduce ideas on a better perspective on Pharmacovigilance to control properly the broad consumption of new-fashionable and new-taste products. Indeed, passed collected data can delineate a strategy for a correct prevision from collected knowledge. It would be Pharmacovigilance management. Improve the management of sometimes harmful side effects and represents a step forward in public health.
The aim of this presentation is to convince that by an appropriate Pharmacovigilance asset and by new data analysis strategy, it is possible to obtain an innovative guide to correct use. Safety and efficacy would improve the general quality of life, as these products are readily available on the market, throughout all pharmacovigilance connected skills.